1. Academic Validation
  2. KUALA: a machine learning-driven framework for kinase inhibitors repositioning

KUALA: a machine learning-driven framework for kinase inhibitors repositioning

  • Sci Rep. 2022 Oct 25;12(1):17877. doi: 10.1038/s41598-022-22324-8.
Giada De Simone # 1 Davide Stefano Sardina # 2 Maria Rita Gulotta 3 Ugo Perricone 3
Affiliations

Affiliations

  • 1 Molecular Informatics Group, Fondazione Ri.MED, Via Filippo Marini 14, 90128, Palermo, Italy. gdesimone@fondazionerimed.com.
  • 2 Molecular Informatics Group, Fondazione Ri.MED, Via Filippo Marini 14, 90128, Palermo, Italy. dssardina@fondazionerimed.com.
  • 3 Molecular Informatics Group, Fondazione Ri.MED, Via Filippo Marini 14, 90128, Palermo, Italy.
  • # Contributed equally.
Abstract

The family of protein kinases comprises more than 500 genes involved in numerous functions. Hence, their physiological dysfunction has paved the way toward drug discovery for Cancer, cardiovascular, and inflammatory diseases. As a matter of fact, Kinase binding sites high similarity has a double role. On the one hand it is a critical issue for selectivity, on the other hand, according to poly-pharmacology, a synergistic controlled effect on more than one target could be of great pharmacological interest. Another important aspect of binding similarity is the possibility of exploit it for repositioning of drugs on targets of the same family. In this study, we propose our approach called Kinase drUgs mAchine Learning frAmework (KUALA) to automatically identify kinase active ligands by using specific sets of molecular descriptors and provide a multi-target priority score and a repurposing threshold to suggest the best repurposable and non-repurposable molecules. The comprehensive list of all kinase-ligand pairs and their scores can be found at https://github.com/molinfrimed/multi-kinases .

Figures
Products